City-based pulmonologist Vyakaranam Nageswar has said that they had administered a rare drug called ‘Omalizumab’ that prevents allergy attack by 60 per cent, for the first time in here on Saturday.
Dr. Nageswar said they administered drug to one chronic patient Uma Devi (50) who had been suffering from asthma for a long time. “The injection was procured from USA by Aswini Hospitals.
Injection therapy
The injection course therapy was started successfully and patient responded well,” he said.
According to him, it is estimated that 30 per cent of Indian population suffers from different kinds of allergy like asthma, rhinitis, sinusitis, skin rashes or food allergies.
There were treatments available for many allergies but certain kind of allergies do not subside for routine allergic treatment, for such conditions a novel research approved drug called Omalizumab works better than any other currently available therapy.
The therapy with Omalizumab injection was available in all developed nations since ten years, but is now becoming available in India as well. Original research molecule called Omalizumab helps the patients to prevent further emergency allergy attacks by almost 60 per cent Dr. Nageshwar said.
Such kind of unique treatment therapy was given for the first time in Warangal at Aswini Hospital Nakkalgutta Hanamkonda.
He said the American manufactured rare and unique injection was available upon specialist prescription, it is a boon for all Central Government employees and ESI employee scheme beneficiaries that they can avail this rare treatment to all uncontrolled allergy patients absolutely free.
The American manufactured unique injection is available upon specialist prescription
